TNF and myositis disease: These are highlighted in Table 2 and include vWF antigen, myositis-specific antibodies (MSA) or myositis-associated antibodies (MAA), muscle biopsy, electromyography (EMG), magnetic resonance imaging (MRI), and ultrasound among the diagnostic resources; and hydroxychloroquine/chloroquine, cyclosporine, cyclophosphamide, rituximab, tumor necrosis factor (TNF) inhibitors, abatacept, and janus kinase (Jak) inhibitors among medications.